-
1
-
-
0037213522
-
Adrenocortical carcinoma: Diagnosis, evaluation and treatment
-
Ng L, Libertine JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5-11.
-
(2003)
J Urol
, vol.169
, pp. 5-11
-
-
Ng, L.1
Libertine, J.M.2
-
2
-
-
0347005232
-
Adrenal cortical cancer
-
Scott HW Jr., ed. Philadelphia: Lippincott
-
McDougal WS. Adrenal cortical cancer. In: Scott HW Jr., ed. Surgery of the Adrenal Glands. Philadelphia: Lippincott, 1996, pp 241-50.
-
(1996)
Surgery of the Adrenal Glands
, pp. 241-250
-
-
McDougal, W.S.1
-
3
-
-
0002855051
-
Adrenal tumors
-
DeVita HSRS, ed. Philadelphia: Lippincott-Raven
-
Norton JA. Adrenal tumors. In: DeVita HSRS, ed. Cancer: Principles and Practic of Oncology. Philadelphia: Lippincott-Raven, 1997, p 1659.
-
(1997)
Cancer: Principles and Practic of Oncology
, pp. 1659
-
-
Norton, J.A.1
-
5
-
-
0001612824
-
Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases
-
MacFarlane DA. Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958;23:155-86.
-
(1958)
Ann R Coll Surg Engl
, vol.23
, pp. 155-186
-
-
MacFarlane, D.A.1
-
6
-
-
0034917097
-
Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
-
Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001;25:891-7.
-
(2001)
World J Surg
, vol.25
, pp. 891-897
-
-
Icard, P.1
Goudet, P.2
Charpenay, C.3
-
7
-
-
0027497040
-
Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature
-
Woolen MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72:3145-55.
-
(1993)
Cancer
, vol.72
, pp. 3145-3155
-
-
Woolen, M.D.1
King, D.K.2
-
9
-
-
0029989715
-
Risk factors for adrenal cancer: An exploratory study
-
Hsing AW, Nam JM, Co Chien HT, et al. Risk factors for adrenal cancer: an exploratory study. Int J Cancer 1996;65:432-6.
-
(1996)
Int J Cancer
, vol.65
, pp. 432-436
-
-
Hsing, A.W.1
Nam, J.M.2
Co, C.H.T.3
-
10
-
-
0002827658
-
Adrenocortical carcinoma: Nonfunctioning and functioning
-
Clark O, Duh QY, eds. W.B. Saunders
-
Proye CA. Adrenocortical carcinoma: nonfunctioning and functioning. In: Clark O, Duh QY, eds. Textbook of Endocrine Surgery. W.B. Saunders, 1997, pp 490-6.
-
(1997)
Textbook of Endocrine Surgery
, pp. 490-496
-
-
Proye, C.A.1
-
11
-
-
0027427863
-
Incidentalomas of the adrenal gland: 36 Operated patients and review of literature
-
Siren JE, Haapiainen RK, Huikuri KT, Sivula AH. Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World J Surg 1993;17:634-9.
-
(1993)
World J Surg
, vol.17
, pp. 634-639
-
-
Siren, J.E.1
Haapiainen, R.K.2
Huikuri, K.T.3
Sivula, A.H.4
-
12
-
-
0030760327
-
Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994
-
Gruppo Piemontese Incidentalomi Surrenalici.
-
Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997;132:914-9.
-
(1997)
Arch Surg
, vol.132
, pp. 914-919
-
-
Terzolo, M.1
Ali, A.2
Osella, G.3
Mazza, E.4
-
13
-
-
0025202883
-
Hormonal evaluation of the patient with an incidentally discovered adrenal mass
-
Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990;323: 1401-5.
-
(1990)
N Engl J Med
, vol.323
, pp. 1401-1405
-
-
Ross, N.S.1
Aron, D.C.2
-
14
-
-
0033396346
-
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma
-
Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999;6:719-26.
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 719-726
-
-
Schulick, R.D.1
Brennan, M.F.2
-
15
-
-
0024513504
-
Pathologic features of prognostic significance in adrenocortical carcinoma
-
Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-6.
-
(1989)
Am J Surg Pathol
, vol.13
, pp. 202-206
-
-
Weiss, L.M.1
Medeiros, L.J.2
Vickery Jr., A.L.3
-
16
-
-
0027051533
-
An eleven-year experience with adrenocortical carcinoma
-
Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-70.
-
(1992)
Surgery
, vol.112
, pp. 963-970
-
-
Pommier, R.F.1
Brennan, M.F.2
-
18
-
-
0035431634
-
Current perspective in the diagnosis and treatment of adrenocortical carcinoma
-
Schteingart DE. Current perspective in the diagnosis and treatment of adrenocortical carcinoma. Rev Endocr Metab Disord 2001;2:323-33.
-
(2001)
Rev Endocr Metab Disord
, vol.2
, pp. 323-333
-
-
Schteingart, D.E.1
-
19
-
-
0027190328
-
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
-
Vassilopoulou-Sellin R, Guinee VF, Klein MJ, et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer 1993;71:3119-23.
-
(1993)
Cancer
, vol.71
, pp. 3119-3123
-
-
Vassilopoulou-Sellin, R.1
Guinee, V.F.2
Klein, M.J.3
-
20
-
-
0035447741
-
Adrenocortical carcinoma. Clinical outcome at the end of the 20th century
-
Vassilopoulou-Sellin R, Schultz PN. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 2001;92:1113-21.
-
(2001)
Cancer
, vol.92
, pp. 1113-1121
-
-
Vassilopoulou-Sellin, R.1
Schultz, P.N.2
-
22
-
-
0036569569
-
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: Continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
-
Abraham J, Bakke S, Rutt A, et al. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 2002;94:2333-43.
-
(2002)
Cancer
, vol.94
, pp. 2333-2343
-
-
Abraham, J.1
Bakke, S.2
Rutt, A.3
-
23
-
-
0034918563
-
Cytotoxic treatment of adrenocortical carcinoma
-
Ahlman H, Khorram-Manesh A, Jansson S, et al. Cytotoxic treatment of adrenocortical carcinoma. World J Surg 2001;25: 927-33.
-
(2001)
World J Surg
, vol.25
, pp. 927-933
-
-
Ahlman, H.1
Khorram-Manesh, A.2
Jansson, S.3
-
24
-
-
0032533913
-
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma
-
Italian Group for the Study of Adrenal Cancer
-
Berruti A, Terzolo M, Pia A, et al. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 1998;83:2194-200.
-
(1998)
Cancer
, vol.83
, pp. 2194-2200
-
-
Berruti, A.1
Terzolo, M.2
Pia, A.3
|